ArticleJournal of imaging informatics in medicine2026
The RATAB Framework: An Interpretable AI-Driven Radiographic Risk Stratification Model for Suspected Lung Lesions.
Article in Journal of imaging informatics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objective of this study is to develop and evaluate the RATAB (Radiological Assessment To Avoid Biopsy) framework as an interpretable, methodology-focused proof-of-concept for malignancy risk ranking on pre-procedural chest radiographs (CXR) using pre-trained TorchXRayVision (TxRV) features, with rigorous leakage-free validation. This retrospective single-center diagnostic accuracy study included patients who underwent transthoracic needle biopsy (TTNB) after a suspicious posteroanterior CXR and had definitive histopathology. The index radiograph was the pre-procedural PA film obtained within 7 days before biopsy. Feature representations extracted from pre-trained TorchXRayVision (TxRV) models were processed using soft-binarization with parameters fixed a priori and evaluated through a strictly leakage-free nested fivefold cross-validation protocol. Model stability was confirmed via a 10 × fivefold repeated cross-validation (50 folds). The primary model (MAIN_B1) was a balanced L2-regularized logistic regression on soft-binarized six-feature inputs with quadratic terms. Uncertainty was quantified by patient-level stratified bootstrap (B = 2000). Reporting followed TRIPOD and CLAIM recommendations. Overall, 285 patients (mean age, 57.8 ± 13.2 years; 160 men) were evaluated, including 206 malignant and 79 benign cases. The primary model achieved a locked 10 × fivefold repeated CV AUC of 0.6883 ± 0.0155 (single fivefold CV AUC = 0.6980 ± 0.0450). Pooled out-of-fold (OOF) AUC was 0.6998 (95% CI 0.6324-0.7659). At the mean training-fold Youden threshold (0.492), OOF sensitivity was 0.670 (95% CI 0.607-0.738), specificity 0.658 (95% CI 0.544-0.759), and cohort PPV 0.836 (95% CI 0.792-0.882); fold-averaged operating metrics were sensitivity 64.6%, specificity 67.1%, and PPV 83.8%. In a theoretical Bayes recalculation at 25% prevalence, PPV was 0.395 (0.328-0.488) and NPV 0.850 (0.824-0.887). Brier score was 0.2210 (95% CI 0.2042-0.2379), with calibration intercept 0.925 (0.848-1.017) and slope 0.980 (0.605-1.457). The RATAB framework delineates the realistic performance boundaries of pre-trained AI representations on CXR. While providing interpretable risk ranking, its prevalence-dependent theoretical predictive values underscore that CXR-based AI cannot substitute for cross-sectional CT evaluation.
Indexed as
Identifiers
42768277What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.